Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-11
1994-01-18
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, 514428, A61K 3140, A61K 3135
Patent
active
052800407
ABSTRACT:
Methods and pharmaceutical compositions for reducing bone loss are disclosed. 3,4-diarylchromans and their pharmaceutically acceptable salts are formulated into medicaments for the treatment of bone loss due to osteoporosis or other conditions. An exemplary 3,4-diarylchroman is centchroman (3,4-trans-2,2-dimethyl-3-phenyl-4-[p-(beta-pyrrolidinoethoxy)phenyl]-7-me thoxy-chroman). Formulations include tablets and other forms suitable for oral administration and controlled-release subdermal implants.
REFERENCES:
patent: 3340276 (1967-09-01), Carney et al.
patent: 3822287 (1974-07-01), Bolger
patent: 4210644 (1980-07-01), Ewing
patent: 4447622 (1984-05-01), Salman et al.
patent: 4489056 (1984-12-01), Himmelstein et al.
patent: 4882347 (1989-11-01), Cozzi et al.
patent: 5015661 (1991-05-01), Walser
patent: 5063234 (1991-11-01), Bryant et al.
CA: vol. 88 (15): No. 99512(v) Kamboj et al (1978).
CA: vol. 117 (7): No. 63184(t)-Singh et al (1992).
Kumari et al., Contracept. 13: 665-676, 1976.
Ray et al., J. Med. Chem. 19: 276-279, 1976.
Johri et al., Contracept. 44: 549-557, 1991.
Salman et al., J. Med. Chem. 26: 592-595, 1983.
Bain et al., J. Bone and Min. Res. 8: 435-442, 1993.
Liu and Howard, The Anat. Rec. 229: 240-250, 1991.
Marie and Hott, Magnesium 6: 100-108, 1987.
Frost and Jee, Bone and Min. 18: 227-236, 1992.
Marshall et al., J. Bone and Min. Res. 5: 955-962, 1990.
Lopez et al., Exp. Clin. Endocrinol. 88: 31-38, 1986.
Broulik, Endocrin. Regul. 25: 217-219, 1991.
Kalu, Bone and Min. 15: 175-192, 1991.
Liu, Bone and Mineral Reserach 5(Suppl. 2): S249, 1990.
Bain Steven D.
Labroo Virender M.
Piggott James R.
Criares T. J.
Holly Julie A.
Parker Gary E.
Waddell Frederick E.
ZymoGenetics Inc.
LandOfFree
Methods for reducing bone loss using centchroman derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for reducing bone loss using centchroman derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing bone loss using centchroman derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1136610